- Home
- AIOT vs TRVI Comparison
AIOT vs TRVI Comparison
Compare AIOT & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIOT
- TRVI
- Stock Information
- Founded
- AIOT 1993
- TRVI 2011
- Country
- AIOT United States
- TRVI United States
- Employees
- AIOT N/A
- TRVI N/A
- Industry
- AIOT Telecommunications Equipment
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- AIOT Telecommunications
- TRVI Health Care
- Exchange
- AIOT Nasdaq
- TRVI Nasdaq
- Market Cap
- AIOT 787.1M
- TRVI 629.8M
- IPO Year
- AIOT N/A
- TRVI 2019
- Fundamental
- Price
- AIOT $4.54
- TRVI $5.96
- Analyst Decision
- AIOT Strong Buy
- TRVI Strong Buy
- Analyst Count
- AIOT 4
- TRVI 8
- Target Price
- AIOT $10.50
- TRVI $19.31
- AVG Volume (30 Days)
- AIOT 2.6M
- TRVI 2.6M
- Earning Date
- AIOT 06-16-2025
- TRVI 08-07-2025
- Dividend Yield
- AIOT N/A
- TRVI N/A
- EPS Growth
- AIOT N/A
- TRVI N/A
- EPS
- AIOT N/A
- TRVI N/A
- Revenue
- AIOT $362,515,000.00
- TRVI N/A
- Revenue This Year
- AIOT $21.96
- TRVI N/A
- Revenue Next Year
- AIOT $10.74
- TRVI N/A
- P/E Ratio
- AIOT N/A
- TRVI N/A
- Revenue Growth
- AIOT 168.61
- TRVI N/A
- 52 Week Low
- AIOT $3.70
- TRVI $2.36
- 52 Week High
- AIOT $8.71
- TRVI $7.48
- Technical
- Relative Strength Index (RSI)
- AIOT 42.44
- TRVI 43.31
- Support Level
- AIOT $4.41
- TRVI $6.05
- Resistance Level
- AIOT $5.07
- TRVI $6.49
- Average True Range (ATR)
- AIOT 0.26
- TRVI 0.53
- MACD
- AIOT 0.00
- TRVI -0.05
- Stochastic Oscillator
- AIOT 25.35
- TRVI 27.62
About AIOT PowerFleet Inc. Common Stock
PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.